Ondansetron Tablet, Orally Disintegrating
Product Images NDC 42291-458

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 42291-458). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 (457 30)

Ondansetron Orally Disintegrating Tablets, USP 4 mg by AvKARE. The label indicates the product contains 30 tablets and is for prescription use only. It includes dosage instructions, storage information, and manufacturer details. The package is designed for oral administration.*

FDA Label Image

30 (458 30)

Ondansetron Orally Disintegrating Tablets, USP, 8 mg, by AvKARE. The label indicates the product contains 30 tablets, prescription use only, and includes dosage information and storage instructions. The packaging shows NDC 42291-458-30 and distributor details for AvKARE in New Jersey.*

FDA Label Image

Structure-base (Structure Base)

Chemical structure of ondansetron, showing its molecular framework with a ketone group, indole ring, and methyl-substituted imidazole moiety.*

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of Ondansetron hydrochloride dihydrate, showing the molecular arrangement of the active ingredient in this human prescription drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.